Company
United StatesPublic company, NYSE: TAKTakeda Pharmaceutical Company Limited (NYSE: TAK), Ammon, ID – FDA Inspections
Inspection records and compliance data for Takeda Pharmaceutical Company Limited in Ammon, ID. 6 FDA inspections on record, last inspected July 30, 2019. Publicly traded as NYSE: TAK.
Company Profile
This profile covers Takeda Pharmaceutical Company Limited based in Ammon, ID, United States.
FDA Inspection History
- FDA inspections
- 6
- OAI
- 0
- VAI
- 1
- NAI
- 5
- Form 483s
- 0
- Warning letters
- 0
First inspected June 11, 2009. Last inspected July 30, 2019.
Most cited issue areas
- Concurrent documentation1 inspection
FDA inspections (6)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 30, 2019 | NAI | Biologics · Blood and Blood Products | 1099764 |
| June 15, 2016 | NAI | Biologics · Blood and Blood Products | 975877 |
| July 9, 2015 | NAI | Biologics · Blood and Blood Products | 934717 |
| August 14, 2013 | NAI | Biologics · Blood and Blood Products | 844248 |
| March 9, 2011 | NAI | Biologics · Blood and Blood Products | 712228 |
| June 11, 2009 | VAI | Biologics · Blood and Blood Products | 599120 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
American National Red Cross (The)
Biomat USA Inc
Proesis Biologics Westmoreland LLC
The Fertility Center at Missouri Baptist Medical Center
Veterans Affairs Medical Center
LifeLink of Puerto Rico
Adnan M. Dahdul, M.D.
Children's Hospital of Alabama Blood Bank
Blood Connection, Inc. (The)
Octapharma Plasma Inc
Company Information
Name
Takeda Pharmaceutical Company Limited
Stock ticker
TAK
Exchange
NYSE
Share price
$21.25
Market cap
$67.1B
Price as of
November 6, 2026
FEI Number
3006611178
Address
2385 S 25th E, Ammon, ID 83406-4902, United States
Country
United States
ID: 25f21beb-881d-4ad2-8a27-91f7e246d4c6